Acidum actylsalicylicum
Aspirin Cardio and Adiro are different trade names for the same medicine.
Acetylsalicylic acid, the active substance contained in Aspirin Cardio, when administered in small doses, long-term, inhibits platelet aggregation. This plays a significant role in preventing the formation of blood clots.
Aspirin Cardio is indicated for use in adults in the following cardiovascular diseases:
This medicine should always be taken exactly as described in this leaflet for the patient or as directed by a doctor or pharmacist.
Aspirin Cardio should be used with caution:
Acetylsalicylic acid may cause bronchospasm and trigger asthma attacks or other hypersensitivity reactions. Patients with asthma, chronic respiratory diseases, hay fever, nasal polyps, and those showing allergic reactions (e.g. skin reactions, itching, hives) to other substances are particularly at risk.
Prior to surgery (including minor procedures, e.g. tooth extraction), patients should inform their doctor about taking Aspirin Cardio.
Acetylsalicylic acid, even in small doses, reduces uric acid excretion from the body.
In patients with a tendency to reduced uric acid excretion, the medicine may cause a gout attack.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.
Acetylsalicylic acid enhances:
Acetylsalicylic acid reduces the effect of:
Certain non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, may reduce the inhibitory effect of Aspirin Cardio on platelet aggregation (thrombocyte aggregation) and thrombus formation (blood clotting). This may reduce the protective effect of Aspirin Cardio against myocardial infarction and stroke.
Metamizole (a substance with analgesic and antipyretic effects) may reduce the effect of acetylsalicylic acid on platelet aggregation (platelet aggregation), if these medicines are taken concomitantly. Therefore, caution should be exercised when taking metamizole in patients receiving acetylsalicylic acid.
Concomitant use of selective serotonin reuptake inhibitors (a group of antidepressant medications) increases the risk of gastrointestinal bleeding.
Aspirin Cardio can be taken concomitantly with the above-mentioned medicines (except for methotrexate at doses of 15 mg per week or higher, when Aspirin Cardio is contraindicated) only after consulting a doctor.
Systemic corticosteroids (corticosteroids/corticosteroids/steroids taken orally or by injection), except for hydrocortisone used as replacement therapy in Addison's disease, taken concomitantly with acetylsalicylic acid: there is a risk of acetylsalicylic acid overdose after discontinuation of corticosteroid therapy, and an increased risk of gastric ulcer and gastrointestinal bleeding due to concomitant use of Aspirin Cardio and systemic corticosteroids.
The treatment effect may be influenced by concomitant use of Aspirin Cardio with medications used in the following conditions:
Alcohol may increase the risk of gastrointestinal side effects.
Enteric-coated tablets should be taken orally, preferably at least 30 minutes before a meal, with a large amount of water.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before taking this medicine.
If the patient will continue or start treatment with Aspirin Cardio during pregnancy, as advised by a doctor, they should take Aspirin Cardio as directed by the doctor and not take a dose higher than recommended.
Pregnancy
Last trimester of pregnancy
Aspirin Cardio should not be taken in doses higher than 100 mg per day during the last three months of pregnancy, as it may harm the unborn child or cause complications during delivery. The medicine may cause renal and cardiac disorders in the unborn child. It may also affect the patient's and child's tendency to bleed and cause delayed or prolonged delivery.
If the patient takes Aspirin Cardio in low doses (up to 100 mg per day), they should be under close obstetric supervision as directed by the doctor.
First and second trimester of pregnancy
Aspirin Cardio should not be taken during the first six months of pregnancy, unless it is absolutely necessary and has been prescribed by a doctor. If the patient requires treatment during this period or is trying to become pregnant, they should take the lowest possible dose for the shortest possible time. If Aspirin Cardio is taken for more than a few days from the 20th week of pregnancy, it may cause renal disorders in the unborn child, leading to a decrease in the amount of amniotic fluid surrounding the fetus (oligohydramnios) or narrowing of the arterial duct (ductus arteriosus) in the child's heart. If treatment is necessary for more than a few days, the doctor may recommend additional monitoring.
Breastfeeding
Acetylsalicylic acid passes into breast milk in small amounts.
Aspirin Cardio does not affect the ability to drive or use machines.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in this leaflet for the patient or as directed by a doctor or pharmacist. In case of doubt, a doctor or pharmacist should be consulted.
The recommended dose is:
Enteric-coated tablets should be taken orally, whole, preferably at least 30 minutes before a meal, with a large amount of water.
During treatment for myocardial infarction, the enteric-coated tablet should be crushed or chewed and swallowed.
If you feel that the effect of the medicine is too strong or too weak, you should consult a doctor or pharmacist.
Overdose in elderly people and small children (taking higher doses than recommended or accidental poisoning) requires special attention, as it can lead to death in these patient groups.
Symptoms of mild poisoning are: dizziness (including vertigo), tinnitus, hearing loss, excessive sweating, nausea and vomiting, headache, disorientation.
In the case of severe poisoning, the following may occur: initially hyperventilation, then shallow breathing and difficulty breathing, up to respiratory failure, fever, ketonuria, respiratory alkalosis, metabolic acidosis, coma, cardiogenic shock, significant decrease in blood glucose levels, presence of blood in the urine, seizures, hallucinations, ketonuria (presence of ketone bodies in the urine), proteinuria (presence of protein in the urine), hypokalemia (decreased potassium levels in the blood).
In the event of an overdose, a doctor or pharmacist should be consulted immediately, and in the case of severe poisoning, the patient should be taken to the hospital immediately.
Treatment of poisoning involves gastric lavage, administration of activated charcoal, and alkaline diuresis. In severe cases, forced alkaline diuresis, peritoneal dialysis, or hemodialysis may be necessary.
In the event of a missed dose, the next dose of Aspirin Cardio should be taken.
A double dose should not be taken to make up for a missed dose.
In case of any further doubts about taking this medicine, a doctor or pharmacist should be consulted.
Like all medicines, Aspirin Cardio can cause side effects, although not everybody gets them.
Common side effects(occurring in 1 to 10 in 100 patients):
Uncommon side effects(occurring in 1 to 10 in 1,000 patients):
Due to the effect of acetylsalicylic acid on platelet aggregation, the risk of bleeding and prolonged bleeding time increases during treatment with Aspirin Cardio, as does the risk of thrombocytopenia. Severe bleeding, such as hemorrhage, can lead to acute or chronic anemia and/or iron deficiency anemia (e.g. due to occult microbleeding) with corresponding laboratory and clinical symptoms, such as asthenia (fatigue), pallor, hypoperfusion (decreased blood flow).
If side effects occur, including any side effects not listed in this leaflet, a doctor or pharmacist should be informed. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl .
By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month.
PP/Al blisters: Store in a temperature below 25°C, in the original packaging.
PVC/Al blisters: Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. A pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.
The package contains 30, 50, 60, or 90 white, round enteric-coated tablets in PP/Al or PVC/Al blisters in a cardboard box.
For more detailed information, the marketing authorization holder or parallel importer should be contacted.
Bayer Hispania, S.L., Av. Baix Llobregat 3-5, 08970 – Sant Joan Despí – Barcelona, Spain
Bayer HealthCare Manufacturing S.r.l., Via delle Groane, 126, 20024 Garbagnate Milanese, Italy
Bayer AG, Kaiser-Wilhelm-Allee, 1, 51373 Leverkusen, Germany
Bayer Bitterfeld GmbH, OT Greppin, Salegaster Chaussee, 1, 06803 – Bitterfeld-Wolfen, Germany
InPharm Sp. z o.o., ul. Strumykowa 28/11, 03-138 Warsaw
InPharm Sp. z o.o. Services sp. k., ul. Chełmżyńska 249, 04-458 Warsaw
Marketing authorization number in Spain, the country of export:723798.3
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.